A dedicated bioimaging function at GSK has shown how integrated microscopy and analytics can deliver quantitative evidence across drug discovery, with a particular focus on complex therapeutic ...

Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...

Affinity Technologies, Inc. , a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced that its wholly owned laboratory subsidiary, Precision Pathology ...